Erythrocyte Membrane Fatty Acid Composition as a Potential Biomarker for Depression
Open Access
- 22 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 26 (6) , 385-395
Abstract
Background: Major depressive disorders is a chronic and severe psychiatric disorder with poor prognosis and quality of life. Abnormal erythrocyte fatty acid (FA) composition in depressed patients were found in our previous study, but the relationship between erythrocyte membrane FA levels and different severity of depressive and anxiety symptoms remains to be explored. Methods: This cross-sectional study included 139 patients with first-diagnosed, drug-naïve depression and 55 healthy controls whose erythrocyte FA composition was analyzed. Patients with depression were divided into severe depression and mild to moderate depression or depression with severe anxiety and mild to moderate anxiety. Then the differences of FA levels among different groups were analyzed. Finally, the receiver operating characteristic curve analysis was applied to identify potential biomarkers in distinguishing the severity of depressive symptoms. Results: Levels of erythrocyte membrane FAs were elevated among patients with severe depression compared with healthy controls or patients with mild to moderate depression of almost all kinds. While C18:1n9t (elaidic acid), C20:3n6 (eicosatrienoic acid), C20:4n6 (arachidonic acid), C22:5n3 (docosapentaenoic acid), total fatty acids (FAs), and total monounsaturated FAs were elevated in patients with severe anxiety compared with patients with mild to moderate anxiety. Furthermore, the level of arachidonic acid, C22:4n6 (docosatetraenoic acid), elaidic acid, and the combination of all 3 were associated with the severity of depressive symptoms. Conclusions: The results suggested that erythrocyte membrane FA levels have the potential to be the biological indicator of clinical characteristics for depression, such as depressive symptoms and anxiety. In the future, more research is needed to explore the causal association between FA metabolism and depression.Keywords
Funding Information
- National Natural Science Foundation of China (81803233)
- Science Foundation of Xiangya Hospital for Young Scholar (2017Q13)
- Natural Science Foundation of Hunan Province (2018JJ3834)
This publication has 62 references indexed in Scilit:
- Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivoProstaglandins, Leukotrienes and Essential Fatty Acids, 2013
- Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorderJournal of Psychiatric Research, 2012
- Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive DisorderJournal of Clinical Psychopharmacology, 2012
- Effects of Altered Maternal Folic Acid, Vitamin B12 and Docosahexaenoic Acid on Placental Global DNA Methylation Patterns in Wistar RatsPLOS ONE, 2011
- Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental DisordersAmerican Journal of Psychiatry, 2010
- Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control StudyPLOS ONE, 2010
- The Conceptual Development of DSM-VAmerican Journal of Psychiatry, 2009
- The c-Jun N-Terminal Kinase Mediates the Induction of Oxidative Stress and Insulin Resistance by Palmitate and Toll-like Receptor 2 and 4 Ligands in 3T3-L1 AdipocytesHormone and Metabolic Research, 2009
- Adipose Inflammation, Insulin Resistance, and Cardiovascular DiseaseJournal of Parenteral and Enteral Nutrition, 2008
- Preferential incorporation of fatty acids at the inside of human erythrocyte membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974